Mushlih, Y., Suryoadji, K.A. and Prasetyawaty, F. 2022. Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran. 49, 12 (Dec. 2022), 693–701. DOI:https://doi.org/10.55175/cdk.v49i12.329.